Zai Lab Limited Stock OTC Markets
Stocks
ZAIL.F
KYG9887T1168
Pharmaceuticals
OTC Markets Traded| Market Cap | 2.87B 2.46B 2.29B 2.11B 3.96B 275B 4.03B 27.08B 10.6B 138B 10.78B 10.54B 454B | P/E 2026 * |
-11.8x | P/E 2027 * | -12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 2.41B 2.07B 1.92B 1.77B 3.33B 231B 3.39B 22.76B 8.91B 116B 9.06B 8.86B 381B | EV / Sales 2026 * |
5.71x | EV / Sales 2027 * | 4.38x |
| Free-Float |
94.05% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Zai Lab Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Ying Du
CEO | Chief Executive Officer | 61 | 2014-03-31 |
Ya jing Chen
DFI | Director of Finance/CFO | 58 | 2023-07-06 |
Rafael Amado
PSD | President | 62 | 2022-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Du
CHM | Chairman | 61 | 2014-03-31 |
John Diekman
BRD | Director/Board Member | 83 | 2016-12-31 |
Peter Wirth
BRD | Director/Board Member | 75 | 2016-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.87B | |
| +3.78% | +5.50% | +46.51% | +3.50% | 80.91B | |
| +5.49% | +20.35% | -38.64% | -38.47% | 53.62B | |
| +0.85% | -4.04% | -2.31% | +30.25% | 50.13B | |
| +0.23% | -3.71% | +11.44% | +170.56% | 47.97B | |
| +4.24% | +8.67% | +63.02% | -15.16% | 31.41B | |
| +176.97% | +187.90% | +520.79% | +71.60% | 25.14B | |
| +4.05% | +6.11% | +51.28% | +100.61% | 25.03B | |
| +1.66% | +2.83% | -3.58% | +212.40% | 21.45B | |
| +0.22% | +5.48% | +65.69% | +127.79% | 16.93B | |
| Average | +2.47% | +3.12% | +79.36% | +73.67% | 39.17B | |
| Weighted average by Cap. | +2.91% | +3.07% | +55.34% | +52.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 423M 362M 337M 311M 583M 40.46B 593M 3.99B 1.56B 20.24B 1.59B 1.55B 66.82B | 569M 487M 453M 418M 785M 54.47B 799M 5.37B 2.1B 27.25B 2.14B 2.09B 89.94B |
| Net income | -245M -210M -195M -180M -338M -23.46B -344M -2.31B -905M -11.74B -920M -900M -38.74B | -187M -160M -149M -137M -258M -17.9B -262M -1.76B -690M -8.95B -702M -687M -29.55B |
| Net Debt | -458M -392M -365M -336M -632M -43.82B -643M -4.32B -1.69B -21.92B -1.72B -1.68B -72.35B | -381M -326M -304M -280M -526M -36.46B -535M -3.59B -1.41B -18.24B -1.43B -1.4B -60.21B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
